Pw. Chen et al., EXPRESSION OF MAGE GENES IN OCULAR MELANOMA DURING PROGRESSION FROM PRIMARY TO METASTATIC DISEASE, Clinical & experimental metastasis, 15(5), 1997, pp. 509-518
Primary melanomas that form within the eye have a unique pattern of di
sease progression as compared with melanomas that form within the skin
, A high percentage of patients (approximately 50%) develop metastatic
tumors that occur predominately in the liver, An unusual characterist
ic of ocular melanomas is the prolonged disease-free interval that ext
ends for many years between the development of primary and metastatic
tumors, It is estimated that the shortest interval between disseminati
on of tumor cells from the eye and the appearance of clinically detect
able metastases is 6 years, A recent report indicated that fresh uveal
melanoma tissue and metastatic tumor biopsies failed to express melan
oma antigen gene (MAGE)-1, MAGE-2, or MAGE-3, In the present study, we
examined the expression of MAGE genes on fresh and cultured tumor cel
ls obtained from an ocular melanoma patient during different stages of
progressive disease, MAGE gene expression was determined by reverse t
ranscription-polymerase chain reaction using MAGE-1, MAGE-2 and MAGE-3
specific primers, Our results demonstrate that primary ocular tumor t
issue and cultured tumor cells both express significant levels of MAGE
-1, 2, and 3 at the time of enucleation, A high percentage of tumor ce
lls within the primary tumor appear to express MAGE as demonstrated by
consistent MAGE expression in 16 tumor cell clones, Metastatic liver
tumors that developed 3 years after enucleation and 18 years after the
initial formation of the primary tumor also expressed high levels of
MAGE-1, -2, and -3, MAGE was expressed on fresh tumor tissue from a si
ngle biopsy and cultured tumor cells obtained from three of four diffe
rent metastatic tumor nodules, When the MAGE-negative metastatic tumor
cells were treated with the demethylating agent 5-Aza-2-Deoxycytidine
(5-Aza-dC), transcription of MAGE-1 was restored, indicating the MAGE
genes were not deleted, Our results demonstrate that in some patients
, MAGE genes are expressed on primary and metastatic ocular melanomas.